Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L), pSE/L-(4-1BBL) (CyOV-0004WQ)
DatasheetThis product is a TNFSF9 encoding oncolytic vaccinia virus, which is based on VACV-WR with E3L deleted.Protein E3 plays a role in the inhibition of multiple cellular antiviral responses activated by dsRNA, such as inhibition of PKR activation, apoptosis, and IFN-mediated antiviral activities.The TNFSF9 has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation.The deletion of E3L and oncolytic-rendered modifications could enhance an immune response to a poxvirus vaccine.This product can be used in oncolytic virotherapy research and vaccinie application.
| Specifications | |
|---|---|
| Family | Poxviridae |
| Species | Vaccinia virus |
| Serotype | Western Reserve |
| Backbone | VACV-WR(ΔE3L) |
| Backbone Background | VACV-WR strain derived from Wyeth through passaging in mice and shown high tumor selectivity and strong oncolytic effect in mouse models.The engineered VACV-WR could further enhance the immune activity and the efficacy of cancer therapies. |
| Gene Modification | ΔE3L |
| Promoter | pSE/L |
| Transgene | 4-1BBL |
| Type of Transgene | Cytokine |
| Related Target/Protein | TNF superfamily member 9 |
| Capsid Modification | None |
| Titer | >1*10^8 PFU |
| Related Diseases | Lung Tumor, HCC |
| Transgene | |
|---|---|
| Alternative Names | CD137L; TNLG5A; 4-1BB-L |
| Gene ID | 8744 |
| Information | |
|---|---|
| Introduction | The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This transmembrane cytokine is a bidirectional signal transducer that acts as a ligand for TNFRSF9/4-1BB, which is a costimulatory receptor molecule in T lymphocytes. This cytokine and its receptor are involved in the antigen presentation process and in the generation of cytotoxic T cells. The receptor TNFRSF9/4-1BB is absent from resting T lymphocytes but rapidly expressed upon antigenic stimulation. The ligand encoded by this gene, TNFSF9/4-1BBL, has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine has also been shown to be required for the optimal CD8 responses in CD8 T cells. This cytokine is expressed in carcinoma cell lines, and is thought to be involved in T cell-tumor cell interaction. |
All services and products are for lab research only, not for any clinical use.
Other products
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L,ΔK3L), pSE/L-(mCCL2)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L), pSE/L-GMCSF
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔK3L), p7.5k-(IL-24)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L), pSE/L-(IL-6)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L,ΔK3L), pSE-(mCCL2)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔK3L), p11k-(TNF-α)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔK3L), pSL-(hIFN-β)
- Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L), pSL-(TNF-α)
